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of diameter (%EDV) and flow velocity (%FV) during reactive hyporemla end 
that otter subllngual nltroglyoertn (%NTG), using ulfrasonography, 
Results: %EDV in both CAD ~nd CHF was stgnifloantly attenuRtod ~s 
compared wdh 10 control nubject~ (C), However, %FV ~nd %NTG was well 
preserved In both groups, VC Improved %EDV In patients with CAD but not 
with CHF and had no effect on %NTG snd %FV, 
%EDV %EOV niter VO %NTG %NTG Riter VC 
C B~ ,~ t ~ 16,2 =1 27 
CHF ~19 .t- 0,?' 4,S ~ 0,8 t4,1 • 1,~ 13,6 ~t, 1,~ 
CAD 91,B ± 0,rt' 6,,'1 t 1, t" 11,0 • t ,6 1~1,? t 1,3 
mean :t 8~M (' ,, p 0,0t~, w %EOV in C" = p -" 0,0fi, v,, %E;OV) 
GonellmtOn: Those rosults ~uggest hnf augmented oxidative stre~ loads 
to endalhollM dysfunction In ths brachial cim~lstton In patients with CAD but 
not with CHF, 
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~ Out©or',~e of Aortic Valve Replacement in Patients 
With Aortic Stenoala and Low Transvalvular 
Gradle~t 
H,M, Connolty, J,K, Oh, H,V, Schafl, V,L, Roger, S,L, Osbom, D,O, Hedge, 
A,J, l~ltk, Mayu C~. to, Rocl~ester, P,':~nesef~ USA 
The outcome ot AVFt tn pts with AS nnd low transvalvular gradient is nat well 
known, Thus We mvmwod 52 such pt~ (34 M', 11] F), moan age 71 :~ 11 ym 
with aortic mean gradient (MG)  • 30 mm HQ and EF :~ 35% who underwent 
AVR b~twesn 1985-g5. 
Preoperative data include: EF 24 :t: 7%, MG ~3 ff 4 mm He, AVA 0,7 ± 0.2 
fm ~ and CO 3.7 ~ 1,2 Vm{n, Corenar~' artery disease (CAD) requiring CABG 
was present in 32 prs (65%), and 45 pts (86%) were severely symptomatic 
(NYHA Class III or IV), 
All pts had AVR (17 mechnntcal, 35 tissue), mean AVR site ?.3 ± 2 ram. 
Nine pts (17%) had .'~imutt~nnous ~nnular patch. 
Hospital mortalily was 21% (11/52); there were 10 late deaths (mean 
follow up 1,5 yrs). Predictom of hospital modeltty included advanced age (p 
0 04S), (78 vs 70 yrs) and smaller AVR size (p = 003), (21 vs 23 mm). 
With muttivanate analysis, AVR size was the only predictor of hospital mor- 
tality. One and 5-yr 9tlrvival WOre GSq~ and 36% respectively. Symptomatic 
=mprevomont was noted in 60% (18 of 30 pts), and EF improved in 74% 128 
of 38 pts), 
Conclu.~ion" 1) Pts with AS, reduced EF and MG represont a high risk 
subset (hospital mortality, 21%), 2) predictors of hospital mortality include age 
and AVR size, 3) EF and symptomatic improvement occurs in the ms[only of 
survivors. Based on this experience we conclude that pts with AS, reduced 
EF end low MG, should not be denied AVR, 
8:45 
1877-2 ~ The Ross Procedure: Searching for the Gold 
Standard for Aortic Root Pathology: Results In 100 
Consecutive Cases 
JH, Ourv, PM, Shah, S,P Hire, C,M,G, Ouran, The International Heart 
In,brute of Montana Foundation, M~SSOUIa, Montana. USA 
~ac'kgro~rn@ The pulmonaP/autograft (PA) has demonstrated superior heine- 
dynamics ot rest and exercise, which together with freedom from thromboe- 
mobolism and chronic anticogutation make the PA an attractive alternative to 
mechanical valve replacement, especially in active young patients with iso. 
lares ~ ~rtic root pathology. Questions remain regarding the safety, Iono-term 
stability, ~nd durability ot both the PA and the pulmonary homograft relative 
to th~ operations' inherent two-valve complexity, 
Methods: This report summarizes the results in 100 consecutive Ross 
procedures, 97 with root replacement and 3 with subcorenary. /HI patients 
received pro and postoperative TEE and all were followed by transthoracic 
echo at yearly intervals, Patient clinical follow-up Is 100% with no cases 
oxcklded (n = 100) with mean age 43 yearn (range 8 to 63 years) 
Hcsufts: There were no operative deaths. 1 patient died of unexplained 
bleeding following hospital discharge, with no other late deaths, 6 patients 
reqaimd reoperation, 3 for autogralt failure (2 partial dehiscence, 1 SBE'), 2 
for progressive pulmonary homograff stenosis, and 1 patient was reopereted 
ior left coronary stenosis fell to be technical 1 patient had >1+ AI on 
flu echo', All patients are NYHA Class I on follow,up, Intraoporative TEE 
immediately alter the procedure demonstrated physiologic gradients (<5 
mm) In all patients wlth no progression on follow.up 1o mix years, mean flu 
901 days), A subgroup of athletes (n = 15) in this ssnes ware exemised to 
exhaustion and demonstrated no significanl difference in aortm gradmnt, or 
exorcise capacity (V02 max) when ¢omparo~ to a matched group of normal 
athletes similarly exsmlsad, 
Conclusion: This series of t00 consecutive RO~ procedures demon, 
strafes no operative mortality, low post.opor~tlve mod~dity and,."omplir~liO~S 
including reopemtton, all of which jt(t~flfies the use use of the Ro~ p.mredum 
in young end middle-seed patients with active lifestyles, 
'Sul~oronary Implantation technique, 
9:00 
~ T h o  Fate of Aorll~ Homografls: Frequency and 
Slgnlflean©e of Ech~.~lrdlographlcll!y OMe~ble 
Compll©atlons In the Long.term Follow-up of SO 
Adults 
C,H, Aflel~hafsr, P,R, Vogt ~ , ~ Oechshn, M, Tunn~ t, K Mayer, R ~n| .  
w C~lrfflology ¢lnd Cfin¢ t~r CaKl~ova~cular Su~f  unwets~ty Hospital. 
Zttnch, Sv~lzerland 
Aortic homogratt (HGI) valves have signilicant!y improved modaltty in patients 
(pts) with aodi~ valve endocardiriS. However, tong,term follow-up data are 
scarce, We revi0wed the ec;ho~ardiographio clat~ of 50 pts (age; 47 ± 15 
yearn) wilh 52 ao~lto HG who were ~n 27 ± 30 months oMor aort',a HG 
implantation, At follow-up, mean pressure gradient of the ao,'l~ valve was 
14 ~ 10 mmHg (range; 1-42), Overall, echocardiographtcally c le f~ 
complications occurred in 32 pts (6~,~,) as shown in the table and ind~ 
anastomotie pseudoaneurysms (PSA), ventdcular septet defects (VSD), pad- 
(orations oi the anterior mitral valve leaflet, degeneratnm aomc regurgitation 
tAR) or stenosis (AS) and mltral regurgitation (MR). (LVOT = fell ventncuta~ 
outflow tract,} 
Comphc;atlofts Pt num~lr Cause tot teope,zattorz 
(%l Pt number (%) 
Anastomotlc PSA 20 (38%) 5 (tO%) 
- PS& causing t~mponaclo 2 t4%) 
Mo~r,~to r severn APt t5 (29%) 4 (8%) 
Moclemto AS 3 (6%) O (0%l 
VSD 6 (12%) 2 (4%) 
Communfahon LVOTlatna 418%) 2 I4%1 
Perforations I slgnlhc~lnt MR 8 (1S'%) 2 (4%) 
Reoperattons worn necossan/13 times: early ( .3  months) in 5 pts or late 
(31 ~- 25 monlhs postoperatively) in 8 pts. Recurrent endocarditis coo'urinal 
=n 7 pts (13%) Hosp=lat mortality was 8% (4 pts); 1 pahent (2%) had a late 
death at reoperation (ischemic cembmvascular accident). 
Conclusions: After aortic HG despde the low eady and late mortatity, 62% 
of these pts have echocardiographically detectable complications including 
PSA, VSD, significant AR or MR, and pedorations of the mitral valve. Reop- 
stations are not uncommon due to PSA, VSD. degenerative changes with 
AR ancPor MR due to leaflet pedoration, Careful echocarcl=ographic follow-up 
is mandatory after aotlic HG operations. 
9:15 
~ Calcium Content in Human Aortic Valves Increases 
Exponentially After Age 60 
Z.G. Tun. R.T+ Savoy-Moore, B.J. Cassia, BS. Fmmm, RJ. Levy. Wayne 
State University School of Medicine. Detroit. MI and University of Michigan. 
Ann Arbor, MI. USA 
Background: Valvular calcification is now the dominant cause of aortic valve 
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stenosis; sevenly of cafcificatio~ across ago groups has not 10eon m ~ n ~  r 
M~'~PhO(~: Aor1~ valvos wore ObteiflO~l for analysis from 238 post mortems 
cortdu~ed bY a medical exammer on in~hvidgala no| known to haw aoff¢ 
valve disease (age range infant to 93 yeal's)~ For compem!on, 44 valves 
excised dunr~l i l .~¢ valve ~opt~_mont (AVR) wero a l~ analy~ed I~y atomic 
Ri~J~: Them w~ an e ~ a l  ~se m valve cak;ium Can. t  (not~ 
m P ,~ td~f og~ 60, M ~  ~ palled'Its ulXtelQoing AVR, 505 !~g/mg 
( ~  101~!~-), w~, 10 t i~  ~t JP r  Ih~n that O| O~o~en~fl~ without 
~ :  There is e~tat  in~rease in human aort~ v~lve cal¢ifi. 
calmn ~ age~ M~an ~ ~ a~ ~ 80 re in  be~w n~ose Of tl~e 
majority Ot paltenls with C~nt~! a~i'l¢ va~ StenO'~ts: 
9:30 
L877.51 ~ Natural Ni~to~/of Aom¢ Valve O l~ Afte~ 
. . . . . .  MRml Valve Oiil~mt!on 
M Va!un, A, Po~e~= Y ACtOr. Y ShaSta, B Vidr~e, A Sagre C a ~  an~ 
CarO~othorac~c Summon/D~oaglmen~ Rab~ Me~:a~ Center. Be~L~ns~n 
~u~d"  Lfftfe iS known aboul ~ natural h~s'forf at aotlie vane (AV) 
d~ease m plls ~ millrai valve (MV) operalmn. There is lack Of darity 
rngar~ng the ~ fo~ su~g~al lreatment Of rn~ AV disease whde :e~r ig  
the MV. We evak~ted the ~ Of AV ~ ar~ the need for further 
&V sutgeqt arnot~ p{s who undeP~ent MV operet~on (~su~Otomy or 
&~hog~.'One h~n£~! fifty o~e p~ (51 M. 10OF; mean age61 ± 13 yr.'s, 
range 35--89) were to l~ed afte~r MV ope~rat~on fo~ an at, erage period Of 13 
± ? ~.'s (r~mge 1-33). erie hu~d~d that one pts ;~r'~o) hod d~m~a~ heart 
~sease. The AV fu~3~n was assessed by an~ogrep~ and transtharac¢ 
Resu/ts. At the time Of MV operation 66 pts (44%) had AV disease: 7 pts 
(5%1 had ~ aon¢ stenos~ (AS), 64 pis (42%) n~ ~ .,~=~-~.,~on 
(AR) and a s~ng~e I~- (0_7%) moderate AR. At the end Of ~-up  period, 1 I0 
pts (73%) had &V d~ease: 3;2 pts (21%) n~tcl AS, 2 patients (1%) moderate 
AS. 2 pts (1%) severe AS. 96 pts (65%) mt~ AR, 6 pcs (4%) moderate AR 
~nd a smg~e pt (0.7%) severe AR_ AV d~sease had ptogresse£1 s~nd~:andy 
sw~-'e the operation m ordy 2 p~s. Su~ pts (3%1 needed AV reptacement after 
an average penod Of 21 ~ 's (range 15-33). No cfm~¢al factor coutcl ~ent~fy 
¢t~e pts wl~o t ro l l  eventuatly need AV replacement. 
~ n . -  Most o! the pls with rn~ AV d~sease at the t~me of MV oper- 
atie~ c~o not ~ to a severe disease. Thus, it seems that "prophytac~c" 
aortic valve replacement is not ~n(hcated. 
9:45 
~ Smoking and Are Associated W'dh the Obesity 
Progression of  Aort ic  Stenosis 
M.V Ngo. JS. Go~ner .  G. Chase. B.J Gersh, RD. F~'c~er, 
D.J. Femicola. Geongetewn Ur~e~ry Hosprtal. Veterans Administration 
Me(lcal Center. Washmglcn D. C , USA 
Backg~un~/: The flaMal history of aod=c stenosis (AS) includes a lafercy 
period followecl by an unp~bte  progress=on. Recent stuclles show an 
assoc, ation between nsk factors for atheroscleresis and the presence of AS. 
We hypothes,ze that atheroscterosrs nsk factors are a~so associated with the 
progression el AS. 
Methods: In a retrospective stu~3y, patients with a d~agnosts of AS IP#- 
continuous wave dappler and a f011ow-up sfuay of at least 6 months were 
included. Independent nsk factorS for the progression of AS were i~ntified 
by stepwise logistic regression analysis. 
Resutts: 123 patients were identified, and complet~ data were o~tained in 
87 patients (mean age 70.7 ¢ 10 yearS, 81% men. and mean foltow-up 2.54 ¢ 
1.6 years). The gradient was considered mild ( < 36 mmHg) in 61% of patients, 
and moderate (36--55 mmHg) in 31%. The mean rate of progression was 
6.3 ± 13 mmHg/year. Of those with mild AS, 36% progressed to moderate 
or severe over 2.9 ± 2.0 years. Independenf clinical factors associated w~th 
a progression of 5 mmHgh/r or greafor included a history of smoking (RR = 
3.06, 95°,o CI = 1.09-861, p = 0034) and a body mass index (kg/m 2) (RR = 
1.16, 95% CI = 1 O3-1.30. p = 0.013). There was an inverse correlation with 
total cholesterol (RR = 0.91 per 10 mg~dl increase. 95% CI = 0.827-0.g99, 
p = 0.0475) only when patients who were taking lipid-lowenng medications 
were included in the analysis. Hypertension, diabetes, age, gender and 
CAD (a history of revasculanzation, myocardial infarction or the presence 
of lesions >50% by catheterization) were not independently associated with 
the progression of AS. 
Conclusion: Body mass index and a history of smoking are independent 
predictors of significant progression of AS defined as -.5 mmHg/year. Inverse 
correlation with cholesterol may reflect cholesterol-lowering treatment as a 
marker for more seve'e disease assoc=alnd with a higher rat0 Of p~;)gress=on~ 
Among the group Of patients with m~ld AS, 36% progressed to read.vile or 
severe during follOw.up 
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veln'rhlvem mbol~ AIlioeklled or Not Wilh Pulmomm!!l 
Embolim 
R. Fa~/re FOr PREPIC tnve~tt~ltem: Clfn¢ Samf /~m,  B~n~.or~ France 
Background: Them was a ~ tO ovatuale t~a nsk/~nefrt ratio Of Low 
Molecular Weight Hepafin (LMWH) in the tnn~al tmalrnenl ~f Deep Veto 
Thronll:]~Si~ (DVI-) in presumed h,gh risk pat,c.~S 
, ~ .  LMI~ (Enoxapann, Enos) was cufnl~red to Ul~raclionateo 
Heparm (UFH) m a ran(lomtsed muftcenter trfft~ (PREPIC) in patients with 
vmlogcap~tcatly proven proximal DVT. A f"~:to~al desl~, was unCen~t con- 
comitantly to evaluate vena cava filter versus nc ~dter. Enox (s.c. I mgtkg b =.d) 
and UFH If.v, aPTl'-adiuSted) wer~ gn~m for II~, day~ and followed by oral 
ant~co~ nt  for at least 3 montl'~. Lung scar,~ t± p~tmo~l,y angmgrams) 
were performed s3,'stemai~lly at Cay 1 and .3zy 10. New asymptomalic 
or symptomatic PE at Day 10 was the primary endpoint. Symptomatic PE, 
recurrent DVT, major bleeding arid Death were bl~n~y evaluated at two years. 
~ .~ -<: 400 p~ants were included (195 En ~.,~, 205 UFH). The mean 
v~a-s 72 ylars. 49% of patients had a mltial PIE arid 90% had at least one 
I: .esumed rink faclor of PE./It day 10, new PE rate was 1.6% far Enox and 
42% to~r uFH (p = 0.14). At 2 years, symplomatic PE, recurrent DV'T ancl 
Death rate were sm~lar (3.g% vs 5.7%, 16.6% vs 15.8%, 20.6% vs 211%, 
respec~ve~,). Bleecling was ~ (8-5% vs 12%, NS). 
Con~uso'~.- Enoxapern~ appears at least a~ effective and sate as UFH 
=n the inltia frea~Tierit of proximal DVT associ;iled or not with Pulmonary 
Embessm i,; presumed high ask p'ttient5 
8:45 
~ Abbreviated Hospitalization Using a for gv'r Novel 
Low Molecular Weight Heparin, Ardeparln: Results 
of  a Randomized Control led T-ial 
SZ Gotdhaber. R.B Momson, L.L Diren. TH ee, Jr, Bnghamana 
Womens Hc,~at, BostOn, MA, USA 
Backgl~und: Although thelow molecular weight hepann, ardepann, has been 
recently approved for prevention of venous thromboembolism after fatal knee 
replacemerit. It has not been studied previously for treatment of acute deep 
vein thrombosis (DVT). 
Methods: We randomized 80 DVT pat~ts, (diagnosed by venous ultra- 
sound) to either a conventional 5 day hospifahzatmn with continuous mira- 
venous unfract~onated hepann (N = 39) (target PT'r 60-80 seconds) or to a 
2 day hospdalizalion with a low molecular weight hepann (N = 41), ardepilfin 
130 anti.Xa umts/kg suboulaneously twice dally (no laboratory monifomlg), 
until a target fNR of 20-3.0 and a steDle oral dose was achieved with war- 
farm. Patients were evaluated clrmcally with 2 and 6 week off~ce visits and 
uno'en~'ent follow-up venous ultrasound at 6 weeks, 
ResuffS: By ultrasound exammahon, 77% improved compared with base- 
line in the an:tepann group vemus 58% who imp~ with unfraCtionated 
hepann (p = 0.08). One major bleed occurred in each group. Median hospital 
charges were $6.500 aJ~ $?.815, respectively (p - 0.0001) Using a patient 
~tisfact=on sconng system where 1 = Excellent and 2 = Very Good, both 
groups reported an average score of t .3 for the care they recaived. 
Conc/usron. These data ff¢iicate that among properly selected patients, 
an abbrewated hospztahzatron usqng ardepann to manage DVT is effocIwo. 
safe. and much less costIy than conventional therapy. 
9:00 
[ -~  Pulmonary Embolism: Diagnosis With Helical 
Computed Tomography Angiography 
SD. Oanadli, A. Vedlard-Baron. F. Bruckert. O. Barre. F Mignon, T. Joseph. 
O. Oubourg, P. Lacombe. Pans V Unn, ersffy .~lmbrotse Pare Hospital. 
France 
Background: Diagnosing pulmon~;'v e .~bohsm (PE] ,e~,,a~ns a major clin=cel 
